The measurement of systolic blood pressure and E/e′ via echocardiography may be the first-line clinical procedure in HFpEF patients with a history of hospitalization, irrespective of the incidence of AF, in addition to the evaluation of laboratory data such as NT-proBNP to predict their prognoses. The gene discussed is NPPB; the disease is atrial fibrillation.